J.P. Morgan Securities LLC
383 Madison Avenue
New York, New York 10179
Morgan Stanley & Co. LLC
1585 Broadway
New York, New York 10036
Leerink Partners LLC
1301 Avenue of the Americas, 12th Floor
New York, New York 10019
February 5, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Jenn Do, Vanessa Robertson, Daniel Crawford and Tim Buchmiller
Re: | Kyverna Therapeutics, Inc. |
Registration Statement on Form S-1, as amended
File No. 333-276523
Request for Acceleration of Effective Date
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Kyverna Therapeutics, Inc. (the “Company”) for acceleration of the effective date of the above-referenced Registration Statement on Form S-1 so that it becomes effective as of 4:00 p.m. Eastern time on February 7, 2024, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Paul Hastings LLP, orally request that such Registration Statement be declared effective.
Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Remainder of Page Intentionally Left Blank; Signature Page Follows]
Very truly yours, | ||
J.P. MORGAN SECURITIES LLC | ||
MORGAN STANLEY & CO. LLC | ||
LEERINK PARTNERS LLC | ||
For themselves and on behalf of the | ||
several Underwriters listed | ||
in Schedule 1 of the Underwriting Agreement | ||
J.P. MORGAN SECURITIES LLC | ||
By: | /s/ Benjamin Burdett | |
Name: Benjamin Burdett | ||
Title: Managing Director | ||
MORGAN STANLEY & CO. LLC | ||
By: | /s/ Chirag D. Surti | |
Name: Chirag D. Surti | ||
Title: Executive Director | ||
LEERINK PARTNERS LLC | ||
By: | /s/ Murphy Gallagher | |
Name: Murphy Gallagher | ||
Title: Senior Managing Director |
[Signature Page to Underwriters’ Acceleration Request]